Treatment of corticosteroid-resistant Graves’ orbitopathy with tocilizumab: a single-centre prospective study-Reference-Cited by-同舟云学术

Treatment of corticosteroid-resistant Graves’ orbitopathy with tocilizumab: a single-centre prospective study

Published:2022-09-05 Issue: Volume: Page:1-7
ISSN:0167-6830
Container-title:Orbit
language:en
Short-container-title:Orbit

Author:

Dorado Cortez Oliver¹²,Grivet Damien¹,Perrillat Nicolas¹,Gain Philippe¹²,Thuret Gilles¹²³

Affiliation:

1. Ophthalmology Department, Saint-Etienne University Hospital, Saint-Etienne, France

2. Corneal Graft Biology, Engineering and Imaging Laboratory, EA2521, Federative Institute of Research in Sciences and Health Engineering, Faculty of Medicine, Jean Monnet University, Saint-Etienne, France

3. Institut Universitaire de France, Paris, France

Funder

no funding

Publisher

Informa UK Limited

Subject

Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01676830.2022.2119262

Reference20 articles.

1. Immune Mechanisms in Thyroid Eye Disease

2. Graves' Ophthalmopathy

3. Graves' Ophthalmopathy

4. Unique Attributes of Orbital Fibroblasts and Global Alterations in IGF-1 Receptor Signaling Could Explain Thyroid-Associated Ophthalmopathy

5. Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term remission of corticosteroid-resistant Graves’ orbitopathy after therapy with tocilizumab;Endokrynologia Polska;2024-02-27

2. Efficiency and Safety of Tocilizumab for the Treatment of Thyroid Eye Disease: A Systematic Review;Ophthalmic Plastic & Reconstructive Surgery;2024-01-12

3. Immunological Processes in the Orbit and Indications for Current and Potential Drug Targets;Journal of Clinical Medicine;2023-12-22

4. Aktuelle Therapieansätze der endokrinen Orbitopathie – sind die zielgerichteten Therapien die Zukunft?;Klinische Monatsblätter für Augenheilkunde;2023-10-05